Ran Nussbaum - Managing Partner and Co-Founder @ Pontifax

Start Free Trial

Pricing

Overview

Number of Founded Organizations

CB Rank (Investor)

111,583

Primary Job Title Managing Partner and Co-Founder
Primary Organization
Pontifax

Location Herzliya, Tel Aviv, Israel
Regions Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA)
Gender Male

Investor Type
obfuscated
obfuscation

Facebook View on Facebook
LinkedIn View on LinkedIn
X (Twitter) View on X

Ran Nussbaum is based out of Herzliya, Tel Aviv, and is the Managing Partner and Co-Founder of Pontifax. Ran previously served as the Board of Director at Keros Therapeutics.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Adcytherix	Pontifax	—	Series A - Adcytherix	obfuscated obfuscation
obfuscated obfuscation	Kamari Pharma	Pontifax	Yes	Series A - Kamari Pharma	obfuscated obfuscation
obfuscated obfuscation	Adcytherix	Pontifax	Yes	Seed Round - Adcytherix	obfuscated obfuscation
obfuscated obfuscation	LB Pharmaceuticals	Pontifax	—	Series C - LB Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	Graviton Bioscience	Pontifax	—	Venture Round - Graviton Bioscience	obfuscated obfuscation
obfuscated obfuscation	Fore Biotherapeutics	Pontifax	Yes	Series C - Fore Biotherapeutics	obfuscated obfuscation
obfuscated obfuscation	Keros Therapeutics	Pontifax	—	Series C - Keros Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Keros Therapeutics	Pontifax	—	Series B - Keros Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Keros Therapeutics	Pontifax	Yes	Series A - Keros Therapeutics	obfuscated obfuscation
obfuscated obfuscation	ArQule	Pontifax	—	Post-IPO Equity - ArQule	obfuscated obfuscation

Jobs

Number of Current Jobs

Ran Nussbaum

is the

Managing Partner and Co-Founder

Pontifax

Pontifax Managing Partner and Co-FounderJan 2004

Board and Advisor Roles

Number of Past Board & Advisor Roles

Organization Name	Title At Company	Start Date	End Date
Keros Therapeutics	Board of Director	Apr 2016	Oct 15, 2025

Related Hubs

Hub Name	CB Rank (Hub)
Tel Aviv Investors	26,028
Middle East Early Stage Venture Investors	4,560
Investors Active in Middle East and North Africa (MENA)	257
Middle East Debt Investors	51,720
Venture Capital Investors with Investments in Middle East	1,268
Early Stage Venture Investors with Investments in Middle East and North Africa (MENA)	1,669
Asia Early Stage Venture Investors	922
Israel Venture Stage Investors	76,535
Israel Late Stage Venture Investors	66,245
Debt Investors Venture Capital Investors	15,895

Recent News and Activity

There is no recent news or activity for this profile.